BioWorld - Friday, December 26, 2025
To read the full story, subscribe or sign in.
Endocrine/metabolic
Chinese scientists divulge new XOR inhibitors
Dec. 3, 2025
Apichope Bio Pharmaceutical Co. Ltd., Apichope Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have synthesized xanthine dehydrogenase/oxidase (XDH; XOR) inhibitors reported to be useful for the treatment of hyperuricemia, gout, arthritis and heart failure.
BioWorld ScienceEndocrine/metabolicPatents